<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101696896</journal-id>
<journal-id journal-id-type="pubmed-jr-id">45929</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Biomed Eng</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat Biomed Eng</journal-id>
<journal-title-group>
<journal-title>Nature biomedical engineering</journal-title>
</journal-title-group>
<issn pub-type="epub">2157-846X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30948824</article-id>
<article-id pub-id-type="pmc">6544395</article-id>
<article-id pub-id-type="doi">10.1038/s41551-018-0252-8</article-id>
<article-id pub-id-type="manuscript">NIHMS1015917</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Bumwhee</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Kunwoo</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Panda</surname>
<given-names>Shree</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonzales-Rojas</surname>
<given-names>Rodrigo</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chong</surname>
<given-names>Anthony</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bugay</surname>
<given-names>Vladislav</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Hyo Min</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brenner</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Murthy</surname>
<given-names>Niren</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Hye Young</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>The Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.</aff>
<aff id="A2"><label>2</label>GenEdit Inc., Berkeley, CA, USA.</aff>
<aff id="A3"><label>3</label>Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.</aff>
<aff id="A4"><label>4</label>These authors contributed equally: Bumwhee Lee, Kunwoo Lee.</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author contributions</p>
<p id="P2">B.L., K.L., R.B., N.M. and H.Y.L. designed the research, and B.L., K.L., S.P., R.G.-R., A.C., H.M.P., VB. and H.Y.L. performed the experiments and analyses. R.G.-R. and S.P generated the videos. B.L., K.L., N.M. and H.Y.L. wrote the manuscript. H.Y.L. supervised the research. All authors discussed the results and commented on the manuscript.</p>
</fn>
<corresp id="CR1"><label>*</label><email>nmurthy@berkeley.edu</email>; <email>leeh6@uthscsa.edu</email></corresp>
<corresp id="CR2"><bold>Correspondence and requests for materials</bold> should be addressed to N.M. or H.Y.L.</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P47">Competing interests</p>
<p id="P48">K.L., H.M.P and N.M. are co-founders of GenEdit Inc. The remaining authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>31</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>2</volume>
<issue>7</issue>
<fpage>497</fpage>
<lpage>507</lpage>
<!--elocation-id from pubmed: 10.1038/s41551-018-0252-8-->
<permissions>
<license license-type="permissions">
<license-p><bold>Reprints and permissions information</bold> is available at <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/reprints">www.nature.com/reprints</ext-link>.</license-p>
</license>
</permissions>
<abstract id="ABS1">
<p id="P3">Technologies that can safely edit genes in the brains of adult animals may revolutionize the treatment of neurological diseases and the understanding of brain function. Here, we demonstrate that intracranial injection of CRISPR–Gold, a nonviral delivery vehicle for the CRISPR–Cas9 ribonucleoprotein, can edit genes in the brains of adult mice in multiple mouse models. CRISPR–Gold can deliver both Cas9 and Cpf1 ribonucleoproteins, and can edit all of the major cell types in the brain, including neurons, astrocytes and microglia, with undetectable levels of toxicity at the doses used. We also show that CRISPR–Gold designed to target the metabotropic glutamate receptor 5 (mGluR5) gene can efficiently reduce local mGluR5 levels in the striatum after an intracranial injection. The effect can also rescue mice from the exaggerated repetitive behaviours caused by fragile X syndrome, a common single-gene form of autism spectrum disorders. CRISPR–Gold may significantly accelerate the development of brain-targeted therapeutics and enable the rapid development of focal brain-knockout animal models.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>